March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the planning and implementation of advanced cardiac laboratories for healthcare providers in the United States. The labs feature technologies across the cardiovascular service line for hospitals and clinics interested in developing laboratories that meet their changing clinical needs.

February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multi-center Reduce-HTN renal denervation clinical study for uncontrolled hypertension.

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.

February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental new drug application (sNDA) filed Dec. 29, 2011 for Xarelto (rivaroxaban).


Based on what readers clicked on throughout 2011 on DIcardiology.com, following is a list of the top 25 most popular stories.

 

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the MynxGrip VCD offers an active, extravascular and patient-friendly vascular closure solution.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now